Analysts Set Vital Farms, Inc. (NASDAQ:VITL) PT at $51.25

Vital Farms, Inc. (NASDAQ:VITL) has been assigned an average recommendation of “Moderate Buy” from the fifteen research firms that are currently covering the company, Marketbeat.com reports. Two investment analysts have rated the stock with a hold recommendation and thirteen have issued a buy recommendation on the company. The average 12 month price objective among brokers that have issued ratings on the stock in the last year is $49.9091.

VITL has been the subject of several recent analyst reports. Cowen reaffirmed a “buy” rating on shares of Vital Farms in a research report on Thursday. Zacks Research cut Vital Farms from a “strong-buy” rating to a “hold” rating in a research note on Friday, November 14th. Morgan Stanley reduced their price objective on Vital Farms from $48.00 to $45.00 and set an “overweight” rating for the company in a research note on Wednesday. Jefferies Financial Group reaffirmed a “buy” rating and issued a $52.00 target price on shares of Vital Farms in a report on Wednesday. Finally, Benchmark restated a “buy” rating on shares of Vital Farms in a research report on Wednesday.

Vital Farms Stock Performance

Shares of Vital Farms stock opened at $33.38 on Thursday. The business has a 50-day simple moving average of $34.32 and a 200-day simple moving average of $39.01. The company has a debt-to-equity ratio of 0.02, a quick ratio of 2.15 and a current ratio of 2.65. Vital Farms has a one year low of $28.87 and a one year high of $53.13. The company has a market cap of $1.49 billion, a PE ratio of 25.29 and a beta of 1.06.

Vital Farms (NASDAQ:VITL) last issued its earnings results on Tuesday, November 4th. The company reported $0.36 earnings per share for the quarter, beating the consensus estimate of $0.30 by $0.06. Vital Farms had a net margin of 8.50% and a return on equity of 20.19%. The firm had revenue of $198.94 million for the quarter, compared to analysts’ expectations of $191.35 million. During the same quarter last year, the company earned $0.16 earnings per share. The firm’s revenue was up 37.2% compared to the same quarter last year. On average, equities research analysts forecast that Vital Farms will post 1.11 EPS for the current fiscal year.

Trending Headlines about Vital Farms

Here are the key news stories impacting Vital Farms this week:

• Positive Sentiment: Telsey Advisory Group reaffirmed an “Outperform” rating, adding institutional support that can help buoy the stock. Telsey Reaffirms Outperform
• Positive Sentiment: DA Davidson and Needham both maintained “buy” recommendations, keeping sell?side sentiment tilted positive despite volatility. DA Davidson Buy Needham Reiterates Buy
• Positive Sentiment: Analyst commentary and research notes highlight long?term growth potential (brand strength, pricing power in premium egg/butter categories), which supports medium?to?longer?term investor thesis. Seeking Alpha: Long?Term Potential
• Neutral Sentiment: Options implied volatility is surging, signaling traders expect a larger near?term price move — raises hedging and trading activity but is direction?agnostic. IV Surge Article
• Neutral Sentiment: Multiple media pieces are assessing valuation after recent volatility, useful for investors reviewing entry points and risk/reward but not an immediate catalyst. Valuation Assessment
• Negative Sentiment: Vital Farms trimmed FY25 revenue guidance to $755M–$765M (from at least $775M), a clear near?term negative that likely pressures the stock until guidance proves conservative. Revenue Cut
• Negative Sentiment: TD Cowen cut its price target from $59 to $44 (still a “buy”) — a notable downward revision that narrows upside expectations. TD Cowen PT Cut (Benzinga)
• Negative Sentiment: BMO cut its target from $60 to $50 (keeps “outperform”), another trimmed target that tempers analyst-driven upside. BMO PT Cut
• Negative Sentiment: Insider selling (Matthew Ohayer sold ~5,000 shares, part of a series of sales) adds to near?term negative optics, though the stake change is small as a percentage of holdings. Insider Sale

Insider Buying and Selling

In related news, CEO Russell Diez-Canseco sold 16,734 shares of the stock in a transaction on Monday, December 15th. The stock was sold at an average price of $35.05, for a total transaction of $586,526.70. Following the completion of the sale, the chief executive officer directly owned 649,684 shares of the company’s stock, valued at $22,771,424.20. This trade represents a 2.51% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, insider Matthew Ohayer sold 25,000 shares of the company’s stock in a transaction on Monday, December 1st. The stock was sold at an average price of $33.17, for a total transaction of $829,250.00. Following the transaction, the insider owned 6,391,190 shares of the company’s stock, valued at approximately $211,995,772.30. The trade was a 0.39% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. In the last three months, insiders sold 86,401 shares of company stock worth $3,008,045. Corporate insiders own 21.30% of the company’s stock.

Institutional Investors Weigh In On Vital Farms

A number of hedge funds have recently added to or reduced their stakes in the company. Exchange Traded Concepts LLC purchased a new stake in shares of Vital Farms during the 3rd quarter worth approximately $28,000. Caitong International Asset Management Co. Ltd acquired a new position in Vital Farms during the third quarter worth $55,000. Virtus Advisers LLC acquired a new position in Vital Farms during the third quarter worth $105,000. Assetmark Inc. boosted its position in Vital Farms by 18.9% during the second quarter. Assetmark Inc. now owns 3,153 shares of the company’s stock worth $121,000 after purchasing an additional 501 shares in the last quarter. Finally, Comerica Bank grew its holdings in Vital Farms by 63.2% in the first quarter. Comerica Bank now owns 4,049 shares of the company’s stock valued at $123,000 after purchasing an additional 1,568 shares during the last quarter. Institutional investors and hedge funds own 98.59% of the company’s stock.

Vital Farms Company Profile

Vital Farms, traded on the NASDAQ under the symbol VITL, is a U.S.-based food company specializing in pasture-raised egg and dairy products. The company partners with a network of family farms across the United States to produce eggs, butter and related items under a certified humane, pasture-centric farming model. Vital Farms’ supply chain emphasizes animal welfare, environmental stewardship and transparent sourcing, appealing to consumers seeking ethically produced, high-quality ingredients.

Founded in 2007 and headquartered in Austin, Texas, Vital Farms began by marketing pasture-raised eggs to health- and ethically minded shoppers.